Relationship between plasma S-adenosylhomocysteine concentration and glomerular filtration rate in children

被引:31
作者
Jabs, K
Koury, MJ
Dupont, WD
Wagner, C
机构
[1] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA
[5] Dept Vet Affairs Med Ctr, Nashville, TN 37202 USA
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2006年 / 55卷 / 02期
关键词
D O I
10.1016/j.metabol.2005.08.025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
S-Adenosylhomocysteine (SAH) is the metabolic precursor of all the homocysteine (Hey) produced in the body. It is formed by the enzyme SAH hydrolase in a reversible reaction. In a previous study we have shown that plasma SAH is a more sensitive indicator of the risk for cardiovascular disease, and in a second study involving patients with renal disease, we also showed that it is a more sensitive indicator of renal insufficiency than plasma Hey. However, in the latter study, the patients with renal disease were older and had a variety of other diseases such as diabetes and primary hypertension, which are associated with vascular disease and which could reduce renal function by involvement of the kidneys. Our objective was to rule out these complicating factors as the cause of the elevated SAH in renal disease and determine whether renal insufficiency alone was the cause of the elevated SAH. We therefore measured SAH, Hey, folate, and vitamin B-12 in 23 patients between the ages of 1 and 18 years with a wide range of renal function, but who had none of these complicating factors. Glomerular filtration rate (GFR) was calculated using serum creatinine according to the Schwartz formula. None of the children were deficient in folate or vitamin B-12. After adjusting for age, folate, and vitamin B-12, there was a modest and insignificant decrease of 0.033 mu mol/L of Hey associated with an increase of 1 mL/min of GFR (95% confidence interval, -0.066 to 0.0002). However, there was a strong and statistically significant association between log(SAH) and log(GFR): P <.0005, R-2 = 0.76. This result suggests that plasma SAH rather than Hey is the metabolite primarily affected in renal disease. We suggest that plasma Hey elevations that have been linked to vascular disease may be due to elevated SAH resulting from renal insufficiency. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:252 / 257
页数:6
相关论文
共 40 条
[1]   The effect of reduced glomerular filtration rate on plasma total homocysteine concentration [J].
Arnadottir, M ;
Hultberg, B ;
NilssonEhle, P ;
Thysell, H .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1996, 56 (01) :41-46
[2]   S-adenosylhomocysteine and the ratio of S-adenosylmethionine to S-adenosylhomocysteine are not related to folate, cobalamin and vitamin B6 concentrations [J].
Becker, A ;
Smulders, YM ;
Teerlink, T ;
Struys, EA ;
de Meer, K ;
Kostense, PJ ;
Jakobs, C ;
Dekker, JM ;
Nijpels, G ;
Heine, RJ ;
Bouter, LM ;
Stehouwer, CDA .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2003, 33 (01) :17-25
[3]   Plasma homocysteine, aortic stiffness, and renal function in hypertensive patients [J].
Bortolotto, LA ;
Safar, ME ;
Billaud, E ;
Lacroix, C ;
Asmar, R ;
London, GM ;
Blacher, J .
HYPERTENSION, 1999, 34 (04) :837-842
[4]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[5]   Measurement of plasma S-adenosylmethionine and S-adenosylhomocysteine as their fluorescent isoindoles [J].
Capdevila, A ;
Wagner, C .
ANALYTICAL BIOCHEMISTRY, 1998, 264 (02) :180-184
[6]   Homocysteine, renal function, and risk of cardiovascular disease [J].
Clarke, R ;
Lewington, S ;
Landray, M .
KIDNEY INTERNATIONAL, 2003, 63 :S131-S133
[7]   Homocysteine and risk of ischemic heart disease and stroke -: A meta-analysis [J].
Clarke, R ;
Collins, R ;
Lewington, S ;
Donald, A ;
Alfthan, G ;
Tuomilehto, J ;
Arnesen, E ;
Bonaa, K ;
Blacher, J ;
Boers, GHJ ;
Bostom, A ;
Bots, ML ;
Grobee, DE ;
Brattström, L ;
Breteler, MMB ;
Hofman, A ;
Chambers, JC ;
Kooner, JS ;
Coull, BM ;
Evans, RW ;
Kuller, LH ;
Evers, S ;
Folsom, AR ;
Freyburger, G ;
Parrot, F ;
Genst, J ;
Dalery, K ;
Graham, IM ;
Daly, L ;
Hoogeveen, EK ;
Kostense, PJ ;
Stehouwer, CDA ;
Hopknis, PN ;
Jacques, P ;
Selhub, J ;
Luft, FC ;
Jungers, P ;
Lindgren, A ;
Lolin, YI ;
Loehrer, F ;
Fowler, B ;
Mansoor, MA ;
Malinow, MR ;
Ducimetiere, P ;
Nygard, O ;
Refsum, H ;
Vollset, SE ;
Ueland, PM ;
Omenn, GS ;
Beresford, SAA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (16) :2015-2022
[8]   HYPERHOMOCYSTEINEMIA - AN INDEPENDENT RISK FACTOR FOR VASCULAR-DISEASE [J].
CLARKE, R ;
DALY, L ;
ROBINSON, K ;
NAUGHTEN, E ;
CAHALANE, S ;
FOWLER, B ;
GRAHAM, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) :1149-1155
[9]  
Clarke S, 2001, HOMOCYSTEINE IN HEALTH AND DISEASE, P63
[10]   Is folate a promising agent in the prevention and treatment of cardiovascular disease in patients with renal failure? [J].
De Vriese, AS ;
Verbeke, F ;
Schrijvers, BF ;
Lameire, NH .
KIDNEY INTERNATIONAL, 2002, 61 (04) :1199-1209